SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
77 hedge funds and large institutions have $81.8M invested in Strongbridge Biopharma plc. in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
22% less capital invested
Capital invested by funds: $106M → $81.8M (-$23.7M)
53% less call options, than puts
Call options by funds: $37K | Put options by funds: $79K
Holders
77
Holding in Top 10
2
Calls
$37K
Puts
$79K
Top Buyers
| 1 | +$7.33M | |
| 2 | +$4.04M | |
| 3 | +$3.1M | |
| 4 |
6CM
683 Capital Management
New York
|
+$2.39M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$2.31M |
Top Sellers
| 1 | -$491K | |
| 2 | -$422K | |
| 3 | -$306K | |
| 4 |
Walleye Capital
New York
|
-$200K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$143K |